Jay Ji
-
- PARP inhibition in cancer therapy 4
- Neutropenia and Cancer Infections 2
-
- Cancer therapeutics and mechanisms 4
- DNA Repair Mechanisms 4
- Advanced Biosensing Techniques and Applications 2
-
- Cancer Genomics and Diagnostics 3
-
- BRCA gene mutations in cancer 2
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- Ralph E. ParchmentJames H. DoroshowShivaani KummarRobert J. KindersJoseph E. TomaszewskiAlice P. ChenLarry RubinsteinOxana K. Pickeral
- Journals
- Molecular Cancer Therapeutics (3 papers)Journal of Clinical Oncology (3 papers)Cancer Research (3 papers)
- Partner nations
- United States
In The Last Decade
Jay Ji
11 papers receiving 286 citations
Peers
Comparison fields: 5 of 63
- Oncology 162
- Molecular Biology 180
- Reproductive Medicine 17
- Physiology 9
- Cancer Research 29
Countries citing papers authored by Jay Ji
This map shows the geographic impact of Jay Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Ji more than expected).
Fields of papers citing papers by Jay Ji
This network shows the impact of papers produced by Jay Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Ji. The network helps show where Jay Ji may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jay Ji, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 1 | |
| 2 | 2013 | 1 | |
| 3 | 2012 | 120 | |
| 4 | 2011 | 21 | |
| 5 | 2011 | 1 | |
| 6 | 2010 | 11 | |
| 7 | 2010 | 1 | |
| 8 | 2010 | 31 | |
| 9 | 2008 | 68 | |
| 10 | Development and validation of a quantitative assay for γH2AX in needle biopsies using topoisomerase I inhibitors | 2007 | 1 |
| 11 | A validated assay for gamma-H2AX as a pharmacodynamic biomarker of response to DNA damage | 2007 | 1 |
| 12 | 2001 | 40 |
About Jay Ji
Jay Ji is a scholar working on Cancer Research, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Statistics and Probability, having authored 12 papers that have together received 297 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), DNA Repair Mechanisms (4 papers), PARP inhibition in cancer therapy (4 papers), Cancer Genomics and Diagnostics (3 papers), Advanced Biosensing Techniques and Applications (2 papers), Neutropenia and Cancer Infections (2 papers), BRCA gene mutations in cancer (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Oncology (162 citations), Molecular Biology (180 citations), Reproductive Medicine (17 citations), Physiology (9 citations) and Cancer Research (29 citations). Jay Ji has collaborated with scholars based in United States. Frequent co-authors include Ralph E. Parchment, James H. Doroshow, Shivaani Kummar, Robert J. Kinders, Joseph E. Tomaszewski, Alice P. Chen, Larry Rubinstein, Oxana K. Pickeral, Nyamkhishig Sambuughin and Henry Rosenberg. Their work appears in journals such as Molecular Cancer Therapeutics, Journal of Clinical Oncology, Cancer Research, Neuromuscular Disorders and The Cancer Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.